Myriad Genetics to Host Investor Event on October 9, 2024

Rhea-AI Impact

(Low)

Rhea-AI Sentiment

(Neutral)

Rhea-AI Summary

Myriad Genetics (NASDAQ: MYGN) has announced an Investor Event scheduled for October 9, 2024, at the Westin Grand Central Hotel in New York City. The event, starting at 9:00 am EDT, will last approximately two hours and feature presentations from CEO Paul J. Diaz and other executive leaders.

Topics to be discussed include:

Long-term growth strategy
Operational initiatives
Scientific and clinical advancements in the product pipeline
Long-term financial goals

In-person attendance requires registration, while a live webcast will be available on Myriad's investor relations website. A replay will be accessible for at least 30 days following the event.

09/05/2024 - 08:00 AM

SALT LAKE CITY, Sept. 05, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Event at the Westin Grand Central Hotel in New York City on October 9, 2024. The in-person event will commence at 9:00 am EDT and last approximately two hours.

Paul J. Diaz, President and CEO, and other members of the Myriad executive leadership team will discuss the company’s long-term growth strategy, operational initiatives, scientific and clinical advancements reflected in its product pipeline, and long-term financial goals.

For those interested in attending the event in person, please register here. For those unable to attend in person, a live webcast of the Investor Event presentation and Q&A will be available on Myriad’s investor relations website at investor.myriad.com. A replay will be posted on Myriad Genetics’ website after the event and will be available for at least 30 days following.

About Myriad Genetics
Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where genetic insights can significantly improve patient care and lower healthcare costs. For more information, visit www.myriad.com.

Investor Contact
Matt Scalo
(801) 584-3532
IR@myriad.com

Media Contact
Glenn Farrell
(385) 318-3718
PR@myriad.com

FAQ

When and where is Myriad Genetics (MYGN) hosting its Investor Event in 2024?

Myriad Genetics (MYGN) is hosting its Investor Event on October 9, 2024, at the Westin Grand Central Hotel in New York City.

What topics will be covered at Myriad Genetics' (MYGN) October 2024 Investor Event?

The event will cover Myriad Genetics' long-term growth strategy, operational initiatives, scientific and clinical advancements in its product pipeline, and long-term financial goals.

How can investors attend or access Myriad Genetics' (MYGN) October 2024 Investor Event?

Investors can attend in person by registering online or access a live webcast of the event on Myriad Genetics' investor relations website at investor.myriad.com.